Details for 2019186196

Up to date per 04.04.2026

Actions

Title / Product Name

SUBLINGUALE FORMULIERUNG VON RILUZOL

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019186196

EP Publication Number

3616686

E-Number

1393310

Language

PCT Number

Publication Date

04.03.2020 A

19.05.2021 B1

Registration Date

19.05.2021

AT Publication Date

15.06.2021

Application Date

17.11.2015

Registration Number

Priorities

21.11.2014

201462083094 P

IPC

A61K 9/00 20060101AFI20201016BHEP

Maximum Duration of Protection

17.11.2035

Owner

Biohaven Pharmaceutical Holding Company Ltd.234 Church Street Suite 301 New Haven, CT 06520US

Representative

No representatives present

Inventor

CORIC, Vladimir7 Richborough Road Madison, CT 06443US

BERMAN, Robert, M.77 Livingston Street New Haven, CT 06511US